Perbedaan Diagnos Laboratorium Utama Tbk. dan Cipta Sarana Medika Tbk.: Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp224 (kapitalisasi pasar 310,75 M, volume 24 jam 963,6 rb), sedangkan Cipta Sarana Medika Tbk. diperdagangkan di Rp63 (kapitalisasi pasar 158,12 M, volume 24 jam 8,21 jt). Perbedaan utamanya: Diagnos Laboratorium Utama Tbk. lebih besar dari sisi kapitalisasi pasar, dan Cipta Sarana Medika Tbk. lebih aktif diperdagangkan (8,21 jt vs 963,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DGNS | DKHH | |
|---|---|---|
Kapitalisasi Pasar | 310,75 M | 158,12 M |
Volume | 963,6 rb | 8,21 jt |
Lot | 9,64 rb | 82,15 rb |
Perputaran | 217,67 jt | 515,2 jt |
Harga Rata-rata | 225,89 | 62,72 |
Nilai Transaksi | 217,67 jt | 515,2 jt |
Harga Ekuilibrium Indikatif | 226 | 63 |
Volume Ekuilibrium Indikatif | 1 rb | 1,33 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Selengkapnya di halaman DKHH →